Adherent strains of coagulau: negative staphylococci (C-NS) were reported to be more pathogenic and resistant to antibiotics and to appear later during hospiralisation than nonadherent ones. Aim of this prospective study was to correlate adherence of C-NS with clinical sepsis and antibiotic mistance and to correlate the time of appearance of adherent with non-adherent strains. Sixty-one C-NS strains isolated from blood cultures in 55 newborn between 1991 and 1993 were included in the study. Adherence was determined according to the qualitative method of Christensen (1982). Of 61 episodes of positive blood culrures 38 (62%) strains had adherence lest positive, 41161 (67%) of episodes were associated with clinical and laboratory signs of sepsis. Of C-NS with positive adherence 28/38 were associated with sepsis, whereas in C-NS with negative adherence 13/23 wen: m x i a t e d with sepsis (differences NS, p3.27). Of C-NS with positive adhcrence 31138 wen: resistant to at least three antibiotics (methicillin, genmycin and chloramphenicol), whereas in C-NS wirh negative adherence 13/23 were resistant to antibiotics (differences NS, p=0.069). No difference was found in the median day of appearance between adherent and non-adherent strains (6th vs. 13.5 th day. p3.415). In this study wc did not find significant differences between adherent and nonadherent swains of C-NS. Performance of a 10 hed paediatric intensive care unit (PICU) in a university children's hospital was assessed in a prospective cohort study of unselected. consequtive admissions. Collected data included primary clinical specialty, PRISM score derived mortality risk. administration of PICU-dependent therapy and vital status at discharge. Effectiveness of care was determined by comparing severity of illness hased predicted mortality 'with vital status at discharge. Efficiency was determined by the adminimation of at least one PICU-dependent therapy or mortality risk exceeding 1 %. 593 patients were included, PICU mortality was 8.4%. The overall performance of the PRISM score based predictive model was found to he well (goodness-of-fit test X2(5)=5.49, p=0.33; area under ROC-curve 0.92). indicating good effectiveness of care. Overall 489 of 593 (82.5%) admissions were efficient, as were 2393 of 3130 (76.5%) PICU days. In cardiovascular surgery patients 800 of 927 (86.3%) PICU days were efficient, in non-surgical patients 142111855 (76.6%), and in other surgery patients 1721347 (49.6%). In conclusion, performance of paediawic intensive care could he determined using objective criteria (mortality risk and administration of PICU-dependent therapy), allowing inter-institutional comparative assessment of quality of care in the future.
In order to identify the incidence a n d natural history of ARDS in children, a prospective survey w a s conducted in German paediatr~c intensiv e c a r e units by questionnaire in 1993. S o far, 3 9 p a t~e n t s beyond the neonatal period h a v e b e e n reported who fulf~lled the predetermined criteria of ARDS. M e d~a n a g e w a s 2 3 months. range 1 month t o 2 0 years. ARDS w a s associated with a primary pulmonary d i s e a s e (predominantly infectious pneumonia) in 17, with a n extrapulmonary d i s e a s e in 1 2 a n d with a mixed pulmonary I extrapulmonary lesion in 9 patients. 5 Patients h a d aquired immunodeficiency. T h e predominent vent~latory mode applied w a s pressure controlled ventilation. ECMO w a s used in 5. HFOV in 2 a n d nitrous oxide in 2 patients. T h e mortality rate of 5 4 % (21139) corresponded to published data. Multiple organ system failure w a s a major complication of ARDS t h e number of affected systems being correlated t o outcome. T h e d a t a of this survey c a n b e used a s a basis for prospective multicenter trials of n e w treatment modalities which a r e urgently n e e d e d to improve the poor prognosis of ARDS in children. Thoraclc surgery, P e d i a t r i c cardiology and Thoracic a n e s t h e s i a , University Hospital Dijkzigt/Sophia, Rotterdam.
The complexity Of c a r d i a c anomalies and t h e mismatch between s i z e of t h e c a t h e t e r and p a t i e n t has l i m i t e d t h e use of continous 4 s a t u r a t i o n monitoring i n i n f a n t s and c h i l d r e n undergoing surgery f o r complex congenital h e a r t d i s e a s e (CCHD)
. Therefore, we evaluated t h e f e a s i b l l l t y o f continuous i n t r a v a s c u l a r f i b r o p t i c SvO> measurement (0-p t i c a t h R , s i z e 4 F c a t h e t e r and Oximetrlx"3 SO,/CO computer) i n 6 p a t i e n t s (mean age 13.0mth; mean weight 8.3kg) with CCHO p a l l l a c e d by a " b i d i r e c t i o n a l cavopulmonary anastomosis" (end t o s i d e s u p e r i o r vena cava t o r i g h t pulmonary anastomosis and c l o s u r e of t h e s u p e r l o r vena c a v a l -r i g h t a t r i a l j u n c t i o n ) . The aim of t h e study was t o e v a l u a t e t h e method of i n s e r t i o n and t h e r e l i a b l i t y of t h e measurement. A f t e r performing t h e anastomosis, t h e f i b r o p t i c c a t h e t e r is t r a n s t h o r a c a l l y introduced and i n s e r t e d through t h e r i g h t atrlum i n t o i n f e r i o r caval vein. The placement of t h e c a t h e t e r is c r u c i a l . This can be a problem due t o i t s migration i n t o l i v e r venes o r entanglement i n t o t h e a t r i a l wall and should be v e r i f i e d with an X-ray. A "I" v i t r o " and "xn vivo" c a l l b r a t i o n should be performed i n t h e OR followed by a " i n vivo" c a l l b r a t i o n i n t h e I C u n i t . This r e s u l t e d I" a r e l i a b l e t r e n d , e l e c t i v e l y used upto 72hrs (5% ranging from 35-80%1, r e a c t i n g r a p i d l y with every event and therapy. However, t h e merit of t h e " a b s o l u t e value" has t o be evaluated f u r t h e r . Conclusion: I n p a t i e n t s with CCHD with r a p i d l y changrng hemodynamic's t h e f i b e r o p t i c c a t h e t e r f o r continuous SO, measurement could be an useful t o o l i n t a i l o r i n g t h e postoperative management.
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CARBAMATE (C) POISONING AND OXIME THERAPY S h a u l S o f e r , M a t i t i a h u L i f s h i t z , E l i e z e r S h a h a k , S h l o m o
Almog, M i c h a l R o t e n b e r g , S o r o k a Med. C e n t e r , B e e r -S h e v a , a n d S h e b a Med. C e n t e r , T e l Hashomer, I s r a e l .
C c o m p o u n d s [acetylcholinesterase(AChE) i n h i b i t o r s ] , a r e w i d e l y u s e d p e s t i c i d e s . T h e i r t o x i c e f f e c t s a r e s i m i l a r t o o r g a n o p h o s p h a t e p o i s o n i n g ( O P P ) , b u t t h e y a r e c o n s i d e r e d less
c o x i c a n d w i t h o u t CNS e f f e c t ; i n f o r m a t i o n o n i n f a n t s i s l i m i t e d . O x i m e s , t h e m a i n s t a y o f OPP t h e r a p y a r e n o t r e c o m m e n d e d i n C p o i s o n i n g . D u r i n g t h e y e a r s 8 9 -9 2 we s t u d i e d 2 6 c h i l d r e n (1-8 y r s ; m e d -2 6 mos) w i t h s e v e r e C p o i s o n i n g : m e t h o m y l ( n = 1 7 ) a n d a l d i c a r b ( n = 9 ) . A l l r e q u i r e d PICU f o r s e v e r e CNS d e p r e s s i o n . A l l w e r e f l a c c i d a n d 8 0 % h a d m i o s i s . A l l w e r e t r e a t e d w i t h a t r o p i n e s u l p h a t e a n d o b i d o x i m e c h l o r i d e a n d r e c o v e r e d w i t h i n 2 4 h . S i n c e o u r o b s e r v a t i o n c o n t r a d i c t s a n i m a l s t u d i e s t h a t o x i m e s e n h a n c e C c h o l i n e r g i c a c t i v i t y , w e s t RBC's p r e t r e a t e d w i t h O P P , b u t h a d n o e f f e c t o n RBC's p r e t r e a t e d w i t h C . We c o n c l u d e t h a t i n i n f a n t s a n d c h i l d r e n C p o i s o n i n g r e s e m b l e s c l i n i c a l l y t h a t o f OPP w i t h m a i n l y CNS e f f e c t . O x i m e s h a v e n o d e l e t e r i o u s e f f e c t o n C p o i s o n i n g a n d AChE b o t h i n v i v o a n d i n v i t r o .
